247 related articles for article (PubMed ID: 34267755)
1. The Ability of AhR Ligands to Attenuate Delayed Type Hypersensitivity Reaction Is Associated With Alterations in the Gut Microbiota.
Abdulla OA; Neamah W; Sultan M; Alghetaa HK; Singh N; Busbee PB; Nagarkatti M; Nagarkatti P
Front Immunol; 2021; 12():684727. PubMed ID: 34267755
[TBL] [Abstract][Full Text] [Related]
2. AhR Ligands Differentially Regulate miRNA-132 Which Targets HMGB1 and to Control the Differentiation of Tregs and Th-17 Cells During Delayed-Type Hypersensitivity Response.
Abdulla OA; Neamah W; Sultan M; Chatterjee S; Singh N; Nagarkatti M; Nagarkatti P
Front Immunol; 2021; 12():635903. PubMed ID: 33679792
[TBL] [Abstract][Full Text] [Related]
3. Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.
Singh NP; Singh UP; Rouse M; Zhang J; Chatterjee S; Nagarkatti PS; Nagarkatti M
J Immunol; 2016 Feb; 196(3):1108-22. PubMed ID: 26712945
[TBL] [Abstract][Full Text] [Related]
4. AhR Activation Leads to Alterations in the Gut Microbiome with Consequent Effect on Induction of Myeloid Derived Suppressor Cells in a CXCR2-Dependent Manner.
Neamah WH; Busbee PB; Alghetaa H; Abdulla OA; Nagarkatti M; Nagarkatti P
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348596
[TBL] [Abstract][Full Text] [Related]
5. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis.
Singh NP; Singh UP; Singh B; Price RL; Nagarkatti M; Nagarkatti PS
PLoS One; 2011; 6(8):e23522. PubMed ID: 21858153
[TBL] [Abstract][Full Text] [Related]
6. TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4+ T Cell Differentiation.
Ehrlich AK; Pennington JM; Bisson WH; Kolluri SK; Kerkvliet NI
Toxicol Sci; 2018 Feb; 161(2):310-320. PubMed ID: 29040756
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of a Xenopus laevis cell line to the aryl hydrocarbon receptor ligands 6-formylindolo[3,2-b]carbazole (FICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Laub LB; Jones BD; Powell WH
Chem Biol Interact; 2010 Jan; 183(1):202-11. PubMed ID: 19799885
[TBL] [Abstract][Full Text] [Related]
8. Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-
Fling RR; Zacharewski TR
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830313
[TBL] [Abstract][Full Text] [Related]
9. Dietary Indole-3-Carbinol Activates AhR in the Gut, Alters Th17-Microbe Interactions, and Exacerbates Insulitis in NOD Mice.
Kahalehili HM; Newman NK; Pennington JM; Kolluri SK; Kerkvliet NI; Shulzhenko N; Morgun A; Ehrlich AK
Front Immunol; 2020; 11():606441. PubMed ID: 33552063
[TBL] [Abstract][Full Text] [Related]
10. Non-dioxin-like AhR ligands in a mouse peanut allergy model.
Schulz VJ; Smit JJ; Huijgen V; Bol-Schoenmakers M; van Roest M; Kruijssen LJ; Fiechter D; Hassing I; Bleumink R; Safe S; van Duursen MB; van den Berg M; Pieters RH
Toxicol Sci; 2012 Jul; 128(1):92-102. PubMed ID: 22491429
[TBL] [Abstract][Full Text] [Related]
11. Editor's Highlight: Ah Receptor Activation Potentiates Neutrophil Chemoattractant (C-X-C Motif) Ligand 5 Expression in Keratinocytes and Skin.
Smith KJ; Boyer JA; Muku GE; Murray IA; Gowda K; Desai D; Amin SG; Glick AB; Perdew GH
Toxicol Sci; 2017 Nov; 160(1):83-94. PubMed ID: 28973351
[TBL] [Abstract][Full Text] [Related]
12. Differential consequences of two distinct AhR ligands on innate and adaptive immune responses to influenza A virus.
Wheeler JL; Martin KC; Resseguie E; Lawrence BP
Toxicol Sci; 2014 Feb; 137(2):324-34. PubMed ID: 24194396
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent transcriptomic and biochemical responses of 6-formylindolo[3,2-b]carbazole (FICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are explained by AHR activation time.
Farmahin R; Crump D; O'Brien JM; Jones SP; Kennedy SW
Biochem Pharmacol; 2016 Sep; 115():134-43. PubMed ID: 27301797
[TBL] [Abstract][Full Text] [Related]
14. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor.
Yuan X; Tong B; Dou Y; Wu X; Wei Z; Dai Y
Biochem Pharmacol; 2016 Feb; 101():87-99. PubMed ID: 26640276
[TBL] [Abstract][Full Text] [Related]
15. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo.
Duarte JH; Di Meglio P; Hirota K; Ahlfors H; Stockinger B
PLoS One; 2013; 8(11):e79819. PubMed ID: 24244565
[TBL] [Abstract][Full Text] [Related]
16. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
17. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.
Kerkvliet NI; Steppan LB; Vorachek W; Oda S; Farrer D; Wong CP; Pham D; Mourich DV
Immunotherapy; 2009 Jul; 1(4):539-47. PubMed ID: 20174617
[TBL] [Abstract][Full Text] [Related]
18. Subfunctionalization of Paralogous Aryl Hydrocarbon Receptors from the Frog Xenopus Laevis: Distinct Target Genes and Differential Responses to Specific Agonists in a Single Cell Type.
Freeburg SH; Engelbrecht E; Powell WH
Toxicol Sci; 2017 Feb; 155(2):337-347. PubMed ID: 27994169
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor signaling modifies Toll-like receptor-regulated responses in human dendritic cells.
Kado S; Chang WLW; Chi AN; Wolny M; Shepherd DM; Vogel CFA
Arch Toxicol; 2017 May; 91(5):2209-2221. PubMed ID: 27783115
[TBL] [Abstract][Full Text] [Related]
20. Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
Rouse M; Singh NP; Nagarkatti PS; Nagarkatti M
Br J Pharmacol; 2013 Jul; 169(6):1305-21. PubMed ID: 23586923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
